Search results
Results from the WOW.Com Content Network
JRCALC is the Joint Royal Colleges Ambulance Liaison Committee. [1] Their role is to provide robust clinical speciality advice to ambulance services within the UK and it publishes regularly updated clinical guidelines [citation needed]. The first meeting of JRCALC was in 1989 and was hosted by the Royal College of Physicians, London. [citation ...
The Joint Royal Colleges Ambulance Liaison Committee provide clinical guidelines on when they should be used. [ 57 ] [ needs update ] [ 58 ] [ 59 ] [ 60 ] Other drugs are given by paramedics with advanced training, either by utilising a patient group direction (PGD) or simply because they are classified as over the counter (OTC) medicines which ...
The college are active participants of a range of groups, including the Joint Royal College Ambulance Liaison Committee and the AACE Clinical Practice Guidelines. [11] The college is also a member of the Royal College of Physicians hosted Intercollegiate Stroke Working Party and Guidelines Development Group, leading the pre-hospital guidelines ...
More than 795,000 people in the U.S. have a stroke each year, which is a leading cause of serious long-term disability. Many of the leading risk factors for stroke are modifiable, making ...
The Joint Commission defines a Primary Stroke Center as follows: "This program is designed for hospitals providing the critical elements to achieve long-term success in improving outcomes for stroke patients." [16] Primary stroke centers have "acute stroke teams" [13] as recommended by the Brain Attack Coalition. The centers should have a ...
The National Institutes of Health Stroke Scale, or NIH Stroke Scale (NIHSS), is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke and aid planning post-acute care disposition, though was intended to assess differences in interventions in clinical trials. The NIHSS was designed for the National ...
Current guidelines recommend antiplatelet therapy for patients with non-cardioembolic ischemic stroke. [ 8 ] [ 9 ] [ 10 ] However, it is widely believed that there is a substantial overlap between ESUS and cardioembolic stroke, clinical trials have assessed the benefit of anticoagulation versus antiplatelet agents for preventing recurrent stroke.
Guidelines on the choice of agents and how best to step up treatment for various subgroups in hypertension (high blood pressure) have changed over time and differ between countries. A Comparison of International Guidelines on Goal Blood Pressure and Initial Therapy for Adults With Hypertension (adapted from JNC 8 guidelines [ 1 ] )